GlassScriptPhysician profile
Carrie Rowan
NPI 1053382663
$767.94
in general payments reported to CMS, 2019-2025
13 companies · $24.13 in 2025
The $24.13 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.69 · 2020: $13.74 · 2022: $203 · 2023: $219 · 2024: $247 · 2025: $24.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $177.66 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $123.22 | 2022-2024 | Vaxelis, Rotateq, Vaxneuvance |
| Alk-Abello, INC | $120.60 | 2024 | Grastek, Odactra, Ragwitek |
| Sanofi Pasteur INC. | $79.71 | 2019-2023 | |
| Corium, LLC | $46.29 | 2022-2023 | Azstarys |
| Hologic Sales and Service, LLC | $41.89 | 2024 | Aptima |
| Seqirus USA INC | $40.55 | 2022 | |
| Supernus Pharmaceuticals, INC. | $38.29 | 2022-2024 | Qelbree |
| Ironshore Pharmaceuticals INC. | $36.20 | 2019-2024 | |
| Organon LLC | $19.44 | 2023 | Nexplanon |
| Phadia US INC. | $16.40 | 2024 | Immunocap |
| Neos Therapeutics, LP | $13.95 | 2019 | |
| Adlon Therapeutics L.P. | $13.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Rowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.